ASTH — Astrana Health, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1083446 ·
Last close
$46.88
Market Cap
$2.32B
52W High
$51.60
52W Low
$27.30
ADV30
690,477
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 965,100,000 | 105,744,000 | 28,528,000 | 14,436,000 | 2,358,827,000 | 478,383,000 | 1,781,371,000 |
| Dec 2025 | 950,526,000 | 95,043,000 | 18,395,000 | 5,999,000 | 2,218,661,000 | 429,474,000 | 1,660,327,000 |
| Sep 2025 | 956,048,000 | 97,192,000 | 19,210,000 | 373,000 | 2,237,186,000 | 462,227,000 | 1,682,462,000 |
| Jun 2025 | 654,808,000 | 77,969,000 | 20,340,000 | 9,423,000 | 1,442,350,000 | 339,703,000 | 904,404,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$114,597,000
Investing CF
$-538,999,000
Financing CF
$569,346,000
CapEx
$-10,106,000
Dividends Paid
$-7,885,000
Buybacks
$-2,253,000
EPS Diluted TTM
$0.46
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$308,379,000
Inventory
—
Receivables
$407,575,000
ST Investments
$1,221,000
EBIT TTM
$89,534,000
Pretax Income TTM
$39,606,000
Interest Exp TTM
$49,928,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,526,479,104
EBITDA
$159,623,008
Free Cash Flow
$287,761,888
Enterprise Value
$2,684,996,864
Total Cash
$478,383,008
Total Debt
$1,065,192,000
Shares Out
49,583,418
Trailing EPS
$0.61
Book Value
$16.35
ROE
5.7%
ROA
3.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,181,769,000 | 78,525,000 | 22,487,000 | 2,218,661,000 | 1,660,327,000 | — | 114,597,000 |
| Dec 2024 | 2,034,540,000 | 89,350,000 | 43,149,000 | 1,354,894,000 | 840,726,000 | — | 52,198,000 |
| Dec 2023 | 1,386,661,000 | 84,613,000 | 60,717,000 | 933,361,000 | 522,593,000 | — | 68,227,000 |
| Dec 2022 | 1,144,163,000 | 104,265,000 | 45,171,000 | 966,213,000 | 407,666,000 | — | 82,128,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$3.42
Max Pain — expiry 2026-07-17
max pain strike: $45.00 · spot: $46.88 · call oi: 4,867 · put oi: 107
Expected Move to 2026-07-17:
±$3.77
(8.04%) —
implied range
$43.10 –
$50.65
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ETY | Eaton Vance Tax-Managed Diversified Equity Income Fund | $2.32B | $14.58 | — |
| GOF | GUGGENHEIM STRATEGIC OPPORTUNITIES FUND | $2.32B | $10.93 | — |
| TY-P | TRI-CONTINENTAL Corp | $2.34B | $41.78 | — |
| FXCNF | FIH Mobile Ltd | $2.34B | $3.00 | — |
| VVX | V2X, Inc. | $2.35B | $74.99 | — |
News headlines (Yahoo Finance, 1h cache)
1 Profitable Stock to Target This Week and 2 We Question
2026-07-10 10:07 · Yahoo
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?
2026-07-02 14:18 · Yahoo
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
2026-06-30 12:19 · Yahoo
Astrana Health (ASTH) Gets Upgraded by Barclays
2026-06-22 12:47 · Yahoo
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
2026-06-15 13:24 · Yahoo
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
2026-06-05 18:56 · Yahoo
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
2026-06-04 21:00 · Yahoo
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
2026-05-26 18:23 · Yahoo
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
2026-05-21 21:16 · Yahoo
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
2026-05-21 03:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.